{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:44:51Z","timestamp":1792525491675,"version":"4.5.0"},"reference-count":417,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.biotechadv.2026.109078","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T14:19:10Z","timestamp":1792333150000},"page":"109078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Programmable bacterial vaccine vectors: A Design\u2013Build\u2013Control framework for precision immune engineering"],"prefix":"10.1016","volume":"94","author":[{"given":"Muhammad","family":"Bakhsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inam Ul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cha Mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8016","key":"10.1016\/j.biotechadv.2026.109078_bb0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"5","author":"Acevedo","year":"2014","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/gut.2007.145839","article-title":"Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines","volume":"57","author":"Aebischer","year":"2008","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cei.13295","article-title":"Emerging viruses and current strategies for vaccine intervention","volume":"196","author":"Afrough","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2025.105343","article-title":"Lipopolysaccharide structural modification in Salmonella Gallinarum targeting lipid a deacylation and O-antigen reduces virulence and endotoxicity with competitive protection against a wild-type challenge in chickens","volume":"165","author":"Aganja","year":"2025","journal-title":"Dev. Comp. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14020126","article-title":"Novel strategies for preventing fungal infections-outline","volume":"14","author":"Agbadamashi","year":"2025","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1675682","article-title":"Precision bacterial immunotherapy: an integrated mechanistic taxonomy and translational roadmap against antimicrobial resistance","volume":"16","author":"Al-Azzani","year":"2025","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb0045","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.vaccine.2005.11.017","article-title":"Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis","volume":"24","author":"Aldwell","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/vim.2017.0026","article-title":"Modes of action for mucosal vaccine adjuvants","volume":"30","author":"Aoshi","year":"2017","journal-title":"Viral Immunol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104088","article-title":"Advancements in synthetic biology-based bacterial cancer therapy: a modular design approach","volume":"190","author":"Arboleda-Garcia","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2026.109078_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micpath.2005.05.004","article-title":"Vector-primed mice display hypo-responsiveness to foreign antigen presented by recombinant Salmonella regardless of the route of delivery","volume":"39","author":"Attridge","year":"2005","journal-title":"Microb. Pathog."},{"issue":"20","key":"10.1016\/j.biotechadv.2026.109078_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262010107","article-title":"Surrogate biomarkers in gene therapy for orphan diseases: validation, application, and regulatory aspects","volume":"26","author":"Ayupova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-026-01726-w","article-title":"A low-endotoxic Salmonella vector with dual bacterial-host promoter expression of Lawsonia intracellularis antigens elicits protective immunity in a murine model","volume":"57","author":"Bakhsh","year":"2026","journal-title":"Vet. Res."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb0070","article-title":"Bivalent Oral vaccine using attenuated Salmonella Gallinarum delivering HA and NA-M2e confers dual protection against H9N2 avian influenza and fowl typhoid in chickens","volume":"13","author":"Bakhsh","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i5.20","article-title":"PLGA nanoparticles in drug delivery: the state of the art","volume":"21","author":"Bala","year":"2004","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2859-12-26","article-title":"A comparative analysis of the properties of regulated promoter systems commonly used for recombinant gene expression in Escherichia coli","volume":"12","author":"Balzer","year":"2013","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01755","article-title":"Challenges for clinical development of vaccines for prevention of hospital-acquired bacterial infections","volume":"11","author":"Bekeredjian-Ding","year":"2020","journal-title":"Front. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.biotechadv.2026.109078_bb0095","article-title":"Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines","volume":"10","author":"Berm\u00fadez-Humar\u00e1n","year":"2011","journal-title":"Microb. Cell Factories"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0100","article-title":"Construction and evaluation of an efficient live attenuated Salmonella choleraesuis vaccine and its ability as a vaccine carrier to deliver heterologous antigens","volume":"12","author":"Bian","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mib.2018.02.009","article-title":"Rational engineering of synthetic microbial systems: from single cells to consortia","volume":"45","author":"Bittihn","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12896-021-00726-2","article-title":"Design of a new lyoprotectant increasing freeze-dried Lactobacillus strain survival to long-term storage","volume":"21","author":"Bodzen","year":"2021","journal-title":"BMC Biotechnol."},{"issue":"20","key":"10.1016\/j.biotechadv.2026.109078_bb0115","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1111\/febs.15054","article-title":"Potential impacts of horizontal gene transfer on human health and physiology and how anthropogenic activity can affect it","volume":"286","author":"Boto","year":"2019","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0125","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2228669","article-title":"Challenges in development of vaccines directed toward antimicrobial resistant bacterial species","volume":"19","author":"Brazzoli","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-023-02291-z","article-title":"Method for plasmid-based antibiotic-free fermentation","volume":"23","author":"Brechun","year":"2024","journal-title":"Microb. Cell Factories"},{"issue":"24","key":"10.1016\/j.biotechadv.2026.109078_bb0135","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.vaccine.2004.11.072","article-title":"Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies","volume":"23","author":"Brennan","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583077","article-title":"Emerging concepts and technologies in vaccine development","volume":"11","author":"Brisse","year":"2020","journal-title":"Front. Immunol."},{"issue":"38","key":"10.1016\/j.biotechadv.2026.109078_bb0145","doi-asserted-by":"crossref","first-page":"13832","DOI":"10.1073\/pnas.0406035101","article-title":"Listeria-based cancer vaccines that segregate immunogenicity from toxicity","volume":"101","author":"Brockstedt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21740-0","article-title":"Applications, challenges, and needs for employing synthetic biology beyond the lab","volume":"12","author":"Brooks","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nmeth.2926","article-title":"Principles of genetic circuit design","volume":"11","author":"Brophy","year":"2014","journal-title":"Nat. Methods"},{"issue":"24","key":"10.1016\/j.biotechadv.2026.109078_bb0160","doi-asserted-by":"crossref","first-page":"8166","DOI":"10.1128\/jb.174.24.8166-8171.1992","article-title":"Structural and functional properties of the p60 proteins from different Listeria species","volume":"174","author":"Bubert","year":"1992","journal-title":"J. Bacteriol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0165","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.vaccine.2009.10.080","article-title":"Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers","volume":"28","author":"Bumann","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2015.08.007","article-title":"Innate and adaptive humoral responses coat distinct commensal bacteria with immunoglobulin A","volume":"43","author":"Bunker","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0175","article-title":"Synthetic biology as driver for the biologization of materials sciences","volume":"11","author":"Burgos-Morales","year":"2021","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v16.i1.10","article-title":"Formulation, stability, and delivery of live attenuated vaccines for human use","volume":"16","author":"Burke","year":"1999","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/md14050090","article-title":"Effect of experimental parameters on alginate\/chitosan microparticles for BCG encapsulation","volume":"14","author":"Caetano","year":"2016","journal-title":"Mar. Drugs"},{"issue":"36","key":"10.1016\/j.biotechadv.2026.109078_bb0190","doi-asserted-by":"crossref","first-page":"15898","DOI":"10.1073\/pnas.1009747107","article-title":"Tracking, tuning, and terminating microbial physiology using synthetic riboregulators","volume":"107","author":"Callura","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12934-015-0313-6","article-title":"Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes","volume":"14","author":"Cano-Garrido","year":"2015","journal-title":"Microb. Cell Factories"},{"issue":"20","key":"10.1016\/j.biotechadv.2026.109078_bb0200","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb0205","article-title":"Recombinant live-attenuated Salmonella vaccine for veterinary use","volume":"12","author":"Chagas","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nchembio.1979","article-title":"'Deadman' and 'passcode' microbial kill switches for bacterial containment","volume":"12","author":"Chan","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.micpath.2010.06.001","article-title":"Construction and characterization of an auxotrophic ctxA mutant of O139 Vibrio cholerae","volume":"49","author":"Chan","year":"2010","journal-title":"Microb. Pathog."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13175","article-title":"Why is Listeria monocytogenes such a potent inducer of CD8+ T-cells?","volume":"22","author":"Chavez-Arroyo","year":"2020","journal-title":"Cell. Microbiol."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0225","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.4049\/jimmunol.174.5.2892","article-title":"Intracellular Salmonella inhibit antigen presentation by dendritic cells","volume":"174","author":"Cheminay","year":"2005","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278471","article-title":"Parallel engineering of environmental bacteria and performance over years under jungle-simulated conditions","volume":"17","author":"Chemla","year":"2022","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0250","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s11033-024-09881-z","article-title":"Application of plasmid stabilization systems for heterologous protein expression in Escherichia coli","volume":"51","author":"Chen","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev. Vaccines"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb0240","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1709794","article-title":"Next-generation vaccines against bacterial pathogens: mRNA and beyond","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109078_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111892","article-title":"Bacterial ghosts-based vaccine and drug delivery systems","volume":"13","author":"Chen","year":"2021","journal-title":"Pharmaceutics"},{"issue":"42","key":"10.1016\/j.biotechadv.2026.109078_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202507820","article-title":"Engineering bacteria as living therapeutics in cancer therapy","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coisb.2017.05.009","article-title":"Advances in bacterial cancer therapies using synthetic biology","volume":"5","author":"Chien","year":"2017","journal-title":"Curr. Opin. Syst. Biol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0270","doi-asserted-by":"crossref","first-page":"285","DOI":"10.18388\/abp.2013_1984","article-title":"Salmonella and cancer: from pathogens to therapeutics","volume":"60","author":"Chorobik","year":"2013","journal-title":"Acta Biochim. Pol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0275","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1007\/s12602-025-10667-3","article-title":"Genetically modified lactic acid bacteria: a promising mucosal delivery vector for vaccines","volume":"18","author":"Chowdhury","year":"2026","journal-title":"Probiot. Antimicrob. Proteins"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12934-015-0213-9","article-title":"A quorum sensing-based in vivo expression system and its application in multivalent bacterial vaccine","volume":"14","author":"Chu","year":"2015","journal-title":"Microb. Cell Factories"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0285","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1086\/315497","article-title":"Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium","volume":"181","author":"Clairmont","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0290","first-page":"113","article-title":"Reasons for instability of bacterial vaccines","volume":"87","author":"Corbel","year":"1996","journal-title":"Dev. Biol. Stand."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109078_bb0295","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s12276-020-0437-6","article-title":"Live biotherapeutic products: the importance of a defined regulatory framework","volume":"52","author":"Cordaillat-Simmons","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109078_bb0300","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4161\/hv.34378","article-title":"ADXS-HPV: a therapeutic Listeria vaccination targeting cervical cancers expressing the HPV E7 antigen","volume":"10","author":"Cory","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0305","first-page":"277","article-title":"Factors influencing the stability of live oral attenuated bacterial vaccines","volume":"87","author":"Cryz","year":"1996","journal-title":"Dev. Biol. Stand."},{"issue":"52","key":"10.1016\/j.biotechadv.2026.109078_bb0310","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2016.10.016","article-title":"Vaccine development: from concept to early clinical testing","volume":"34","author":"Cunningham","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb0315","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI0216941","article-title":"Bacterial infectious disease control by vaccine development","volume":"110","author":"Curtiss","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0320","first-page":"35","article-title":"Selective delivery of antigens by recombinant bacteria","volume":"146","author":"Curtiss","year":"1989","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0325","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/IAI.00693-08","article-title":"Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo","volume":"77","author":"Curtiss","year":"2009","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1615\/CritRevImmunol.v30.i3.30","article-title":"New technologies in using recombinant attenuated Salmonella vaccine vectors","volume":"30","author":"Curtiss","year":"2010","journal-title":"Crit. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0335","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1590\/S1517-83822014000400001","article-title":"Live bacterial vaccine vectors: an overview","volume":"45","author":"da Silva","year":"2014","journal-title":"Braz. J. Microbiol."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb0340","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1128\/aem.62.10.3662-3667.1996","article-title":"Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin","volume":"62","author":"de Ruyter","year":"1996","journal-title":"Appl. Environ. Microbiol."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb0345","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1128\/AEM.69.8.4455-4462.2003","article-title":"Spread of recombinant DNA by roots and pollen of transgenic potato plants, identified by highly specific biomonitoring using natural transformation of an Acinetobacter sp","volume":"69","author":"de Vries","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2859-5-23","article-title":"Live bacterial vaccines--a review and identification of potential hazards","volume":"5","author":"Detmer","year":"2006","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01499","article-title":"M cells: intelligent engineering of mucosal immune surveillance","volume":"10","author":"Dillon","year":"2019","journal-title":"Front. Immunol."},{"issue":"7614","key":"10.1016\/j.biotechadv.2026.109078_bb0360","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0365","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.imlet.2018.03.006","article-title":"Live bacterial vaccine vector and delivery strategies of heterologous antigen: a review","volume":"197","author":"Ding","year":"2018","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0370","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4142\/jvs.2018.19.2.232","article-title":"Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge","volume":"19","author":"Ding","year":"2018","journal-title":"J. Vet. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0375","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10311-017-0670-y","article-title":"Chitosan nanoparticles preparation and applications","volume":"16","author":"Divya","year":"2018","journal-title":"Environ. Chem. Lett."},{"issue":"15","key":"10.1016\/j.biotechadv.2026.109078_bb0380","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.vaccine.2008.01.044","article-title":"Heterologous prime\u2013boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction","volume":"26","author":"Dom\u00e8nech","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb0385","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/AEM.02462-09","article-title":"Novel antibiotic-free plasmid selection system based on complementation of host auxotrophy in the NAD de novo synthesis pathway","volume":"76","author":"Dong","year":"2010","journal-title":"Appl. Environ. Microbiol."},{"issue":"18","key":"10.1016\/j.biotechadv.2026.109078_bb0390","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2174\/1381612823666170112124303","article-title":"A new vaccine delivery vehicle and adjuvant candidate: Bordetella pertussis inactivated whole cells entrapped in alginate microspheres","volume":"23","author":"Dounighi","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124222","article-title":"Engineered attenuated probiotic Escherichia coli oral vaccine provides effective protection against monkeypox virus by eliciting specific systemic and mucosal immunity","volume":"334","author":"Duan","year":"2026","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb0400","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1128\/IAI.67.10.5133-5141.1999","article-title":"Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium","volume":"67","author":"Dunstan","year":"1999","journal-title":"Infect. Immun."},{"issue":"2\u20133","key":"10.1016\/j.biotechadv.2026.109078_bb0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0928-8244(03)00065-8","article-title":"In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium","volume":"37","author":"Dunstan","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","article-title":"Bacteria-cancer interactions: bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109078_bb0415","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.4049\/jimmunol.172.11.6858","article-title":"Bacterial ghosts are an efficient delivery system for DNA vaccines","volume":"172","author":"Ebensen","year":"2004","journal-title":"J. Immunol."},{"issue":"45","key":"10.1016\/j.biotechadv.2026.109078_bb0420","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2008.08.024","article-title":"Formulation of a live bacterial vaccine for stable room temperature storage results in loss of acid, bile and bile salt resistance","volume":"26","author":"Edwards","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0425","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/apb.2022.0020","article-title":"FDA guidance on shedding and environmental impact in clinical trials involving gene therapy products","volume":"27","author":"Eisenman","year":"2022","journal-title":"Appl Biosaf"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0430","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/IAI.01328-06","article-title":"Th1 and Th2 cells help CD8 T-cell responses","volume":"75","author":"Ekkens","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567116","article-title":"Artificial intelligence in vaccine research and development: an umbrella review","volume":"16","author":"El Arab","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2025.1620572","article-title":"Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics-yesterday, today, and tomorrow","volume":"8","author":"Elfatimi","year":"2025","journal-title":"Front. Artif. Intell."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0445","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21315\/mjms2024.31.6.2","article-title":"Live attenuated bacterial vectors as vehicles for DNA vaccine delivery: a mini review","volume":"31","author":"Eng","year":"2024","journal-title":"Malays. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0450","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12985-023-02183-z","article-title":"The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection","volume":"20","author":"Faghihkhorasani","year":"2023","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0455","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biologicals.2012.04.004","article-title":"Extraneous agent detection in vaccines--a review of technical aspects","volume":"40","author":"Farsang","year":"2012","journal-title":"Biologicals"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0460","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01220-16","article-title":"aroA-deficient Salmonella enterica serovar typhimurium is more than a metabolically attenuated mutant","volume":"7","author":"Felgner","year":"2016","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/v14030520","article-title":"Strategies to develop a mucosa-targeting vaccine against emerging infectious diseases","volume":"14","author":"Feng","year":"2022","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb0470","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00343-25","article-title":"Listeria monocytogenes adenosine auxotrophs are impaired for intracellular and extracellular growth but retain potent immunogenicity","volume":"93","author":"Feng","year":"2025","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jenvman.2023.118754","article-title":"Assessing the environmental fate of rAAV in activated sludge and water: implications for environmental risk assessments and GMO regulatory frameworks","volume":"345","author":"Fleischmann","year":"2023","journal-title":"J. Environ. Manag."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0480","article-title":"Listeria monocytogenes as a vector for cancer immunotherapy: current understanding and Progress","volume":"6","author":"Flickinger","year":"2018","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0485","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00438-023-01994-7","article-title":"Random transposon mutagenesis identifies genes essential for transformation in Methanococcus maripaludis","volume":"298","author":"Fonseca","year":"2023","journal-title":"Mol. Gen. Genomics."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb0490","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.4049\/jimmunol.155.10.4775","article-title":"Induction of cell-mediated immune responses to human immunodeficiency virus type 1 gag protein by using Listeria monocytogenes as a live vaccine vector","volume":"155","author":"Frankel","year":"1995","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259807","article-title":"Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle","volume":"17","author":"Freudenberger Catanzaro","year":"2022","journal-title":"PLoS ONE"},{"issue":"42","key":"10.1016\/j.biotechadv.2026.109078_bb0500","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/j.vaccine.2013.07.049","article-title":"A phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA","volume":"31","author":"Frey","year":"2013","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.biotechadv.2026.109078_bb0505","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1128\/JVI.74.21.9987-9993.2000","article-title":"Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens","volume":"74","author":"Friedman Rachel","year":"2000","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb0510","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s44320-024-00067-0","article-title":"Bacterial live therapeutics for human diseases","volume":"20","author":"Frutos-Grilo","year":"2024","journal-title":"Mol. Syst. Biol."},{"issue":"35","key":"10.1016\/j.biotechadv.2026.109078_bb0515","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.vaccine.2013.12.026","article-title":"The delicate balance in genetically engineering live vaccines","volume":"32","author":"Galen","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0520","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/icb.2009.31","article-title":"Salmonella enterica serovar Typhi live vector vaccines finally come of age","volume":"87","author":"Galen","year":"2009","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0525","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/IAI.00916-09","article-title":"A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors","volume":"78","author":"Galen","year":"2010","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0530","doi-asserted-by":"crossref","first-page":"e0012621","DOI":"10.1128\/mmbr.00126-21","article-title":"How it all begins: bacterial factors mediating the colonization of invertebrate hosts by beneficial symbionts","volume":"86","author":"Ganesan","year":"2022","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13060659","article-title":"Engineering and evaluation of a live-attenuated vaccine candidate with enhanced type 1 fimbriae expression to optimize protection against Salmonella typhimurium","volume":"13","author":"Garc\u00eda","year":"2025","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0540","first-page":"339","article-title":"Salmonella vaccines for use in humans: present and future perspectives","volume":"26","author":"Garmory","year":"2002","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0545","article-title":"A bacterial expression vector archive (BEVA) for flexible modular assembly of Golden Gate-compatible vectors","volume":"9","author":"Geddes","year":"2018","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0550","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0966-842X(01)02259-4","article-title":"The E. coli alpha-hemolysin secretion system and its use in vaccine development","volume":"10","author":"Gentschev","year":"2002","journal-title":"Trends Microbiol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0555","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1051\/vetres:2006012","article-title":"Mucosal delivery of vaccines in domestic animals","volume":"37","author":"Gerdts","year":"2006","journal-title":"Vet. Res."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0560","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/131.5.553","article-title":"Isolation and characterization of gal E mutant ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine","volume":"131","author":"Germanier","year":"1975","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb0565","article-title":"Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities","volume":"9","author":"Ghattas","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0570","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.aquaculture.2015.04.035","article-title":"Assessment of immune response and protection against bacterial coldwater disease induced by a live-attenuated vaccine delivered orally or intraperitoneally to rainbow trout, Oncorhynchus mykiss (Walbaum)","volume":"446","author":"Ghosh","year":"2015","journal-title":"Aquaculture"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0575","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.addr.2017.05.003","article-title":"Designer outer membrane vesicles as immunomodulatory systems\u2013reprogramming bacteria for vaccine delivery","volume":"114","author":"Gnopo","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb0580","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/infdis\/jiq171","article-title":"B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus","volume":"203","author":"Goenka","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0585","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.addr.2012.09.007","article-title":"Protein release from alginate matrices","volume":"64","author":"Gombotz","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0590","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1208\/s12249-013-0027-1","article-title":"A review of the advancements in probiotic delivery: conventional vs. non-conventional formulations for intestinal flora supplementation","volume":"15","author":"Govender","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0595","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s42003-018-0175-7","article-title":"Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform","volume":"1","author":"Graham","year":"2018","journal-title":"Commun. Biol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb0600","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/IAI.01219-10","article-title":"Iron-regulated lysis of recombinant Escherichia coli in host releases protective antigen and confers biological containment","volume":"79","author":"Guan","year":"2011","journal-title":"Infect. Immun."},{"issue":"33","key":"10.1016\/j.biotechadv.2026.109078_bb0605","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.vaccine.2017.06.052","article-title":"Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses","volume":"35","author":"Guarino","year":"2017","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109078_bb0610","article-title":"Recent advancements in non-invasive vaccination strategies","volume":"13","author":"Gulani","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0615","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67292","article-title":"Intestinal goblet cells sample and deliver lumenal antigens by regulated endocytic uptake and transcytosis","volume":"10","author":"Gustafsson","year":"2021","journal-title":"Elife"},{"issue":"14","key":"10.1016\/j.biotechadv.2026.109078_bb0620","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1128\/jb.177.14.4121-4130.1995","article-title":"Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter","volume":"177","author":"Guzman","year":"1995","journal-title":"J. Bacteriol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0630","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13567-017-0442-5","article-title":"Bacterial ghosts as adjuvants: mechanisms and potential","volume":"48","author":"Hajam","year":"2017","journal-title":"Vet. Res."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00872","article-title":"An influenza HA and M2e based vaccine delivered by a novel attenuated Salmonella mutant protects mice against homologous H1N1 infection","volume":"8","author":"Hajam","year":"2017","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0635","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0640","first-page":"635","article-title":"The double-edged sword: how evolution can make or break a live-attenuated virus vaccine","volume":"4","author":"Hanley","year":"2011","journal-title":"Evolution (N Y)"},{"issue":"42","key":"10.1016\/j.biotechadv.2026.109078_bb0645","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1016\/j.vaccine.2015.08.085","article-title":"Freeze-drying of live virus vaccines: A review","volume":"33","author":"Hansen","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0650","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-1119(87)90167-3","article-title":"Control of cloned gene expression by promoter inversion in vivo: construction of improved vectors with a multiple cloning site and the Ptac promoter","volume":"56","author":"Hasan","year":"1987","journal-title":"Gene"},{"issue":"7270","key":"10.1016\/j.biotechadv.2026.109078_bb0655","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature08529","article-title":"Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response","volume":"462","author":"Hase","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0660","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/s41467-024-45893-w","article-title":"Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements","volume":"15","author":"Hayashi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0665","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.fsi.2021.12.043","article-title":"Development and efficacy of Streptococcus iniae live-attenuated vaccines in Nile tilapia, Oreochromis niloticus","volume":"121","author":"Heckman","year":"2022","journal-title":"Fish Shellfish Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0670","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/fmb.11.144","article-title":"Salmonella enterica as a vaccine carrier","volume":"7","author":"Hegazy","year":"2012","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0675","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tibtech.2024.07.010","article-title":"Microbial messengers: nucleic acid delivery by bacteria","volume":"43","author":"Heggie","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2026.1760257","article-title":"AI-driven discovery in protein science for immunology and infectious disease research","volume":"6","author":"Helmy","year":"2026","journal-title":"Front. Bioinform."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0685","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/iai.63.5.2047-2053.1995","article-title":"Listeria monocytogenes p60 supports host cell invasion by and in vivo survival of attenuated Salmonella typhimurium","volume":"63","author":"Hess","year":"1995","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0690","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11274-026-04783-7","article-title":"Bacterial ghosts (BGs): a promising approach as candidate vaccine","volume":"42","author":"Hetta","year":"2026","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2023.105058","article-title":"Salmonella delivers H9N2 influenza virus antigens via a prokaryotic and eukaryotic dual-expression vector and elicits bivalent protection against avian influenza and fowl typhoid","volume":"149","author":"Hewawaduge","year":"2023","journal-title":"Dev. Comp. Immunol."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb0700","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001812","article-title":"Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery","volume":"10","author":"Ho","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0705","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13567-018-0560-8","article-title":"Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs","volume":"49","author":"Hoelzer","year":"2018","journal-title":"Vet. Res."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb0710","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1073\/pnas.92.7.2904","article-title":"Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity","volume":"92","author":"Hohmann","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 4","key":"10.1016\/j.biotechadv.2026.109078_bb0715","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0720","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1128\/iai.38.1.136-140.1982","article-title":"Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation","volume":"38","author":"Hooke","year":"1982","journal-title":"Infect. Immun."},{"issue":"8444","key":"10.1016\/j.biotechadv.2026.109078_bb0725","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(85)92252-4","article-title":"Live attenuated bacterial vaccines: new approaches for safety and efficacy","volume":"1","author":"Hooke","year":"1985","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0730","article-title":"Mobile genetic elements as central drivers of antimicrobial resistance: molecular mechanisms, evolutionary ecology, one health implications and control strategies","volume":"15","author":"Hossain","year":"2026","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb0735","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1021\/acs.nanolett.5b00570","article-title":"Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy","volume":"15","author":"Hu","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0745","first-page":"498","article-title":"Advances in delivery technologies-powered cancer vaccines","volume":"61","author":"Huang","year":"2026","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0740","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1038\/s41467-024-51182-3","article-title":"Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.engmic.2026.100275","article-title":"Prospects and challenges in using engineered lactic acid bacteria in aquaculture applications","volume":"6","author":"Huang","year":"2026","journal-title":"Eng. Microbiol."},{"issue":"28","key":"10.1016\/j.biotechadv.2026.109078_bb0755","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2009.03.053","article-title":"Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins","volume":"27","author":"Husseiny","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0760","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12934-023-02100-7","article-title":"Mucosal immunization with lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice","volume":"22","author":"Hwang","year":"2023","journal-title":"Microb. Cell Factories"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0765","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/03079457.2019.1616673","article-title":"Alginate-coated chitosan microparticles encapsulating an oral plasmid-cured live Salmonella enterica serovar Gallinarum vaccine cause a higher expression of interferon-gamma in chickens compared to the parenteral live vaccine","volume":"48","author":"Ibe","year":"2019","journal-title":"Avian Pathol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0770","article-title":"Nanoparticle technologies in precision oncology and personalized vaccine development: challenges and advances","volume":"10","author":"Imani","year":"2025","journal-title":"Int. J. Pharm. X"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb0775","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.4014\/jmb.1003.03020","article-title":"Microencapsulation of live probiotic bacteria","volume":"20","author":"Islam","year":"2010","journal-title":"J. Microbiol. Biotechnol."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060947","article-title":"Bacterial spore-based delivery system: 20 years of a versatile approach for innovative vaccines","volume":"13","author":"Isticato","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0785","article-title":"The JMU-SalVac-system: a novel, versatile approach to oral live vaccine development","volume":"12","author":"Iwanowitsch","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/ph18121772","article-title":"Advances in lipid-polymer hybrid nanoparticles: design strategies, functionalization, oncological and non-oncological clinical prospects","volume":"18","author":"Jacob","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0800","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-2958.1996.6411358.x","article-title":"A stringently controlled expression system for analysing lateral gene transfer between bacteria","volume":"21","author":"Jaenecke","year":"1996","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0795","first-page":"29","article-title":"Construction of plasmid vectors bearing a NotI-expression cassette based on the lac promoter","volume":"2","author":"Jaenecke","year":"1999","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0805","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01212","article-title":"Serotype-independent protection against invasive pneumococcal infections conferred by live vaccine with lgt deletion","volume":"10","author":"Jang","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0810","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2469416","article-title":"Harnessing live vectors for cancer vaccines: advancing therapeutic immunotherapy","volume":"21","author":"Jani","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0815","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1128\/IAI.01265-10","article-title":"In vivo regulation of the Vi antigen in Salmonella and induction of immune responses with an in vivo-inducible promoter","volume":"79","author":"Janis","year":"2011","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0820","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/1078-0432.CCR-20-2065","article-title":"Intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors","volume":"27","author":"Janku","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0825","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.884862","article-title":"Oral mRNA vaccines against infectious diseases- A bacterial perspective [invited]","volume":"13","author":"Jawalagatti","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0830","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jare.2021.07.007","article-title":"Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection","volume":"36","author":"Jawalagatti","year":"2022","journal-title":"J. Adv. Res."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2026.106651","article-title":"Attenuation mechanisms and vaccine potential of the serial passage-derived Pasteurella multocida strain PMZ8 in ducks","volume":"105","author":"Ji","year":"2026","journal-title":"Poult. Sci."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0840","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nbt.2508","article-title":"RNA-guided editing of bacterial genomes using CRISPR-Cas systems","volume":"31","author":"Jiang","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110460","article-title":"Efficient chemical hydrophobization of lactic acid bacteria - one-step formation of double emulsion","volume":"147","author":"Jiang","year":"2021","journal-title":"Food Res. Int."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0850","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13060606","article-title":"Recombinant Mycobacterium bovis BCG-based HIV vaccine: failures and promising approaches for a successful vaccine strategy","volume":"13","author":"Joseph-Munn\u00e9","year":"2025","journal-title":"Vaccines"},{"issue":"7873","key":"10.1016\/j.biotechadv.2026.109078_bb0855","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.biotechadv.2026.109078_bb0860","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1128\/JVI.79.14.8716-8723.2005","article-title":"Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin expressing human immunodeficiency virus type 1 gag","volume":"79","author":"Kanekiyo","year":"2005","journal-title":"J. Virol."},{"issue":"2\u20133","key":"10.1016\/j.biotechadv.2026.109078_bb0865","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-8244(03)00063-4","article-title":"Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization","volume":"37","author":"Kang","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb0870","doi-asserted-by":"crossref","DOI":"10.34133\/bmr.0005","article-title":"Lyoprotectant constituents suited for lyophilization and reconstitution of stem-cell-derived extracellular vesicles","volume":"28","author":"Kang","year":"2024","journal-title":"Biomater. Res."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0875","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membrane vesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0880","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.dci.2013.04.012","article-title":"Immune responses of poultry to Newcastle disease virus","volume":"41","author":"Kapczynski","year":"2013","journal-title":"Dev. Comp. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0885","article-title":"Challenges and prospects in the development of a universal SARS-CoV-2 vaccine","volume":"14","author":"Karczmarzyk","year":"2026","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0890","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2009.10.021","article-title":"\u201cSmart\u201d alginate\u2013hydroxypropylcellulose microbeads for controlled release of heparin","volume":"385","author":"Karewicz","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb0895","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10101578","article-title":"Outer membrane vesicles: an emerging vaccine platform","volume":"10","author":"Kashyap","year":"2022","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109078_bb0900","doi-asserted-by":"crossref","DOI":"10.1007\/s00284-024-03916-1","article-title":"Invasive fungal infections in immunocompromised conditions: emphasis on COVID-19","volume":"81","author":"Kaur","year":"2024","journal-title":"Curr. Microbiol."},{"issue":"52","key":"10.1016\/j.biotechadv.2026.109078_bb0905","doi-asserted-by":"crossref","first-page":"85929","DOI":"10.18632\/oncotarget.13231","article-title":"Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model","volume":"7","author":"Kawaguchi","year":"2016","journal-title":"Oncotarget"},{"issue":"46","key":"10.1016\/j.biotechadv.2026.109078_bb0910","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1021\/la303043n","article-title":"Encapsulation of lactic acid bacteria in colloidosomes","volume":"28","author":"Keen","year":"2012","journal-title":"Langmuir"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb0915","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11071264","article-title":"The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria","volume":"11","author":"Khalid","year":"2023","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb0925","article-title":"Freeze-drying of mRNA-LNPs vaccines: a review","volume":"13","author":"Khan","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"21","key":"10.1016\/j.biotechadv.2026.109078_bb0920","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2007.03.007","article-title":"Ability of SPI2 mutant of S. Typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans","volume":"25","author":"Khan","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb0930","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mabi.201000388","article-title":"Advances in mucoadhesion and mucoadhesive polymers","volume":"11","author":"Khutoryanskiy","year":"2011","journal-title":"Macromol. Biosci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0945","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13567-018-0509-y","article-title":"Oral immunization with a novel attenuated Salmonella typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection","volume":"49","author":"Kim","year":"2018","journal-title":"Vet. Res."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb0940","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjc.6604526","article-title":"Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases","volume":"99","author":"Kim","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb0935","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.165","article-title":"Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines","volume":"46","author":"Kim","year":"2014","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0950","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41541-024-00873-5","article-title":"The role of correlates of protection in overcoming barriers to vaccine development and demonstrating efficacy","volume":"9","author":"King","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0955","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41541-024-00872-6","article-title":"Realising the potential of correlates of protection for vaccine development, licensure and use: short summary","volume":"9","author":"King","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.biotechadv.2026.109078_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02345","article-title":"The roles of Peyer's patches and microfold cells in the gut immune system: relevance to autoimmune diseases","volume":"10","author":"Kobayashi","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105127","article-title":"Freeze-drying for the preservation of immunoengineering products","volume":"25","author":"Kommineni","year":"2022","journal-title":"iScience"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb0975","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1128\/IAI.00831-09","article-title":"Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen","volume":"77","author":"Kong","year":"2009","journal-title":"Infect. Immun."},{"issue":"27","key":"10.1016\/j.biotechadv.2026.109078_bb0970","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1073\/pnas.0803801105","article-title":"Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment","volume":"105","author":"Kong","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.biotechadv.2026.109078_bb0980","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1073\/pnas.1321321111","article-title":"Programmable bacteria detect and record an environmental signal in the mammalian gut","volume":"111","author":"Kotula","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb0985","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12866-016-0876-3","article-title":"Bacterial genome engineering and synthetic biology: combating pathogens","volume":"16","author":"Krishnamurthy","year":"2016","journal-title":"BMC Microbiol."},{"issue":"36","key":"10.1016\/j.biotechadv.2026.109078_bb0990","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2010.06.087","article-title":"Bacterial ghosts (BGs)\u2014advanced antigen and drug delivery system","volume":"28","author":"Kudela","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb0995","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/foz007","article-title":"Yeast-based vaccines: new perspective in vaccine development and application","volume":"19","author":"Kumar","year":"2019","journal-title":"FEMS Yeast Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1000","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/07388551.2025.2536808","article-title":"Whole recombinant yeast-based vaccines: concept, importance, issues, and future scope","volume":"46","author":"Kumar","year":"2026","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejpb.2016.03.027","article-title":"A stable live bacterial vaccine","volume":"103","author":"Kunda","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2025.111083","article-title":"Multi-route induction of Salmonella-based vaccine delivery elicits protective immunity against FV3-like ranavirus in an ornamental fish model","volume":"169","author":"Kwon","year":"2026","journal-title":"Fish Shellfish Immunol."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb1010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","article-title":"Exploiting bacteria for cancer immunotherapy","volume":"21","author":"Kwon","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1020","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11071232","article-title":"Oral vaccines: a better future of immunization","volume":"11","author":"Kwong","year":"2023","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020449","article-title":"Beyond the matrix: the many non-ECM ligands for integrins","volume":"19","author":"LaFoya","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"42","key":"10.1016\/j.biotechadv.2026.109078_bb1030","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2019.08.032","article-title":"Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system","volume":"37","author":"Lan","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1035","article-title":"Bacteria-responsive nanostructured drug delivery systems for targeted antimicrobial therapy","volume":"38","author":"Landa","year":"2025","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1040","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4161\/bbug.1.5.12540","article-title":"The bacterial ghost platform system: production and applications","volume":"1","author":"Langemann","year":"2010","journal-title":"Bioeng. Bugs"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1045","first-page":"1171","article-title":"Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk","volume":"11","author":"Leblanc","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1050","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00061-18","article-title":"Lactobacillus mucosal vaccine vectors: immune responses against bacterial and viral antigens","volume":"3","author":"LeCureux","year":"2018","journal-title":"mSphere"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41589-018-0056-x","article-title":"Next-generation biocontainment systems for engineered organisms","volume":"14","author":"Lee","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5173(92)90353-4","article-title":"In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers","volume":"78","author":"Lehr","year":"1992","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1065","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12020238","article-title":"The potential harmful effects of genetically engineered microorganisms (GEMs) on the intestinal microbiome and public health","volume":"12","author":"Lerner","year":"2024","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb1070","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1128\/aem.61.10.3592-3597.1995","article-title":"Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying","volume":"61","author":"Leslie","year":"1995","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1075","series-title":"Vaccines - the History and Future","article-title":"GMO regulatory aspects of novel investigational vaccine candidates","author":"Leunda","year":"2019"},{"issue":"8541","key":"10.1016\/j.biotechadv.2026.109078_bb1090","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"329","author":"Levine","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm0103-99","article-title":"Can needle-free administration of vaccines become the norm in global immunization?","volume":"9","author":"Levine","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1085","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41541-025-01280-0","article-title":"Advances and prospects of respiratory mucosal vaccines: mechanisms, technologies, and clinical applications","volume":"10","author":"Li","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"48","key":"10.1016\/j.biotechadv.2026.109078_bb1110","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202514661","article-title":"Spatial transcriptomics and snRNA-seq expose CAF niches orchestrating dual stromal-immune barriers in hepatocellular carcinoma","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1073\/pnas.0811697106","article-title":"Evaluation of new generation Salmonella enterica serovar typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"33","key":"10.1016\/j.biotechadv.2026.109078_bb1100","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1016\/j.vaccine.2022.06.046","article-title":"Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a virus-like particles induces a protective immune response against porcine circovirus type 2 in mice","volume":"40","author":"Li","year":"2022","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/bit.27596","article-title":"New technologies in developing recombinant-attenuated bacteria for cancer therapy","volume":"118","author":"Liang","year":"2021","journal-title":"Biotechnol. Bioeng."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1120","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/vaccines3040940","article-title":"Live-attenuated bacterial vectors: tools for vaccine and therapeutic agent delivery","volume":"3","author":"Lin","year":"2015","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jcyt.2024.04.067","article-title":"The science and practice of current environmental risk assessment for gene therapy: a review","volume":"26","author":"Liu","year":"2024","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1130","doi-asserted-by":"crossref","DOI":"10.3390\/biom14010133","article-title":"Salmonella typhimurium vaccine candidate delivering infectious bronchitis virus S1 protein to induce protection","volume":"14","author":"Liu","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.synbio.2025.12.008","article-title":"Multi-gene co-expression systems in E. coli: from single-vector designs to programmable expression platforms","volume":"12","author":"Liu","year":"2026","journal-title":"Synth. Syst. Biotechnol."},{"issue":"16","key":"10.1016\/j.biotechadv.2026.109078_bb1140","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202517730","article-title":"Attenuated bacteria-based tumor therapy: clinical application risks, marketing approval restrictions, and coping strategies","volume":"13","author":"Liu","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1145","article-title":"Advancing vaccine technology through the manipulation of pathogenic and commensal bacteria","volume":"29","author":"Lloren","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acs.bioconjchem.7b00738","article-title":"Targeted strategies for mucosal vaccination","volume":"29","author":"Longet","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114946","article-title":"Precision nose-to-brain therapeutics: advances in drug delivery systems and emerging preclinical models","volume":"395","author":"Lu","year":"2026","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1160","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109078_bb1165","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1021\/acsnano.1c03092","article-title":"Metal\u2013organic framework encapsulated whole-cell vaccines enhance humoral immunity against bacterial infection","volume":"15","author":"Luzuriaga","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1170","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-023-37225-1","article-title":"Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb1175","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1128\/IAI.73.10.7011-7013.2005","article-title":"Role of B cells in vaccine-induced immunity against coccidioidomycosis","volume":"73","author":"Magee","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1180","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6638269","article-title":"Genetically engineered microorganisms and their impact on human health","volume":"2024","author":"Mahdizade Ari","year":"2024","journal-title":"Int. J. Clin. Pract."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1185","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2025.111346","article-title":"Development of a multi-epitope vaccine candidate targeting blood-stage of malaria through immunoinformatics approach","volume":"86","author":"Mandal","year":"2025","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03731","article-title":"Stability and structural properties of bee pollen protein hydrolysate microencapsulated using maltodextrin and whey protein concentrate","volume":"6","author":"Maqsoudlou","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2020.100079","article-title":"VANGUARD(R)crLyme: a next generation Lyme disease vaccine that prevents B. Burgdorferi infection in dogs","volume":"6","author":"Marconi","year":"2020","journal-title":"Vaccine X"},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1205","doi-asserted-by":"crossref","DOI":"10.3390\/genes15030261","article-title":"Antibiotic-free gene vectors: a 25-year journey to clinical trials","volume":"15","author":"Marie","year":"2024","journal-title":"Genes (Basel)"},{"issue":"22","key":"10.1016\/j.biotechadv.2026.109078_bb1210","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1128\/JB.181.22.7143-7148.1999","article-title":"Chromosomal integration of heterologous DNA in Escherichia coli with precise removal of markers and replicons used during construction","volume":"181","author":"Martinez-Morales","year":"1999","journal-title":"J. Bacteriol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1215","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00118-25","article-title":"Multivalent vaccines for invasive Salmonella disease: need, rationale, and immunological foundations","volume":"94","author":"Mastroeni","year":"2026","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00253-021-11713-0","article-title":"Current view on novel vaccine technologies to combat human infectious diseases","volume":"106","author":"Mati\u0107","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1225","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fux052","article-title":"The effect of bacterial chemotaxis on host infection and pathogenicity","volume":"42","author":"Matilla","year":"2018","journal-title":"FEMS Microbiol. Rev."},{"issue":"9\u201310","key":"10.1016\/j.biotechadv.2026.109078_bb1230","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.vaccine.2003.09.031","article-title":"Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner","volume":"22","author":"Mauriello","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1235","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2019.1695476","article-title":"Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination","volume":"8","author":"McCright","year":"2020","journal-title":"Tissue Barriers"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1240","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","article-title":"Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts","volume":"133","author":"Medical Advisory Committee of the Immune Deficiency, F","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"13\u201314","key":"10.1016\/j.biotechadv.2026.109078_bb1245","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0264-410X(00)00354-6","article-title":"Use of live bacterial vaccine vectors for antigen delivery: potential and limitations","volume":"19","author":"Medina","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1250","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-016-0468-9","article-title":"Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications","volume":"15","author":"Michon","year":"2016","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101433","article-title":"Outer membrane vesicle vaccines","volume":"50","author":"Micoli","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1260","doi-asserted-by":"crossref","DOI":"10.3389\/frmbi.2024.1441290","article-title":"Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing","volume":"3","author":"Microbiome Therapeutics Innovation, G","year":"2024","journal-title":"Front. Microbiomes"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1265","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00253-005-0107-6","article-title":"10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis","volume":"68","author":"Mierau","year":"2005","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/pathogens4020157","article-title":"Antibiotic-free selection in biotherapeutics: now and forever","volume":"4","author":"Mignon","year":"2015","journal-title":"Pathogens"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1275","article-title":"Spray drying: from a traditional technology to modern biotechnological applications","volume":"10","author":"Milanesi","year":"2025","journal-title":"Int. J. Pharm. X"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1280","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/IAI.00110-15","article-title":"Avoidance of autophagy mediated by PlcA or ActA is required for Listeria monocytogenes growth in macrophages","volume":"83","author":"Mitchell","year":"2015","journal-title":"Infect. Immun."},{"issue":"21\u221222","key":"10.1016\/j.biotechadv.2026.109078_bb1285","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/hum.2022.090","article-title":"Regulatory consideration for the nonclinical safety assessment of gene therapies","volume":"33","author":"Moffit","year":"2022","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1290","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2118831","article-title":"High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure","volume":"14","author":"Molina Ortiz","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1295","article-title":"Two centuries of vaccination: historical and conceptual approach and future perspectives","volume":"11","author":"Montero","year":"2023","journal-title":"Front. Public Health"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb1300","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1021\/acsmaterialslett.5c00238","article-title":"Biocircuitry and living programmable materials: the next frontier in synthetic living systems","volume":"7","author":"Morones-Ram\u00edrez","year":"2025","journal-title":"ACS Mater. Lett."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1305","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1534\/genetics.110.120782","article-title":"Lambda red recombineering in Escherichia coli occurs through a fully single-stranded intermediate","volume":"186","author":"Mosberg","year":"2010","journal-title":"Genetics"},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb1310","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114091","article-title":"Advances in fungal vaccine development: progress in the face of emerging challenges","volume":"28","author":"Moses","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1315","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.757858","article-title":"The diverse applications of recombinant BCG-based vaccines to target infectious diseases other than tuberculosis: an overview","volume":"12","author":"Mouhoub","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1008131","article-title":"Comparative study of subcutaneous, intramuscular, and oral administration of bovine pathogenic Escherichia coli bacterial ghost vaccine in mice","volume":"13","author":"Mu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1325","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/764542","article-title":"Induction of specific CD8 T cells against intracellular bacteria by CD8 T-cell-oriented immunization approaches","volume":"2010","author":"Nagata","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb1330","article-title":"Beyond the Resistome: molecular insights, emerging therapies, and environmental drivers of antibiotic resistance","volume":"14","author":"Nass","year":"2025","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1335","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1340","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-026-01393-0","article-title":"Evaluation of safety and efficacy of an auxotrophic aroA mutant live attenuated vaccine against piscine Streptococcus agalactiae infection","volume":"11","author":"Nie","year":"2026","journal-title":"NPJ Vaccines"},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109078_bb1345","article-title":"Immunogenicity and protective efficacy of a multi-antigen Mycobacterium tuberculosis subunit vaccine in mice","volume":"12","author":"Nisa","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1350","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1172\/JCI28045","article-title":"In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines","volume":"116","author":"Nishikawa","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1355","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12070643","article-title":"Nucleic acid hybrids as advanced antibacterial Nanocarriers","volume":"12","author":"Obuobi","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1360","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.1999.0206","article-title":"Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree","volume":"79","author":"Oettinger","year":"1999","journal-title":"Tuber. Lung Dis."},{"issue":"30","key":"10.1016\/j.biotechadv.2026.109078_bb1365","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.vaccine.2021.06.010","article-title":"Cytoplasmic expression of a model antigen with M cell-targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route","volume":"39","author":"Oh","year":"2021","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.biotechadv.2026.109078_bb1370","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.vaccine.2011.01.093","article-title":"Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines","volume":"29","author":"Ohtake","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2024.106998","article-title":"Leveraging artificial intelligence in vaccine development: a narrative review","volume":"224","author":"Olawade","year":"2024","journal-title":"J. Microbiol. Methods"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-021-00294-8","article-title":"Vaccines for human fungal diseases: close but still a long way to go","volume":"6","author":"Oliveira","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1385","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.2839","article-title":"Limiting the metabolic burden of recombinant protein expression during selection yields pools with higher expression levels","volume":"35","author":"Ong","year":"2019","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114401","article-title":"Sustained delivery approaches to improving adaptive immune responses","volume":"187","author":"Ou","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1201.051043","article-title":"Making better influenza virus vaccines?","volume":"12","author":"Palese","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1400","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2018.00244","article-title":"Use of the human vaccine, Mycobacterium bovis Bacillus Calmette Gu\u00e9rin in deer","volume":"5","author":"Palmer","year":"2018","journal-title":"Front. Vet. Sci."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1405","doi-asserted-by":"crossref","first-page":"97","DOI":"10.38212\/2224-6614.3540","article-title":"Regulatory framework and challenges for live biotherapeutic products in Taiwan","volume":"33","author":"Pan","year":"2025","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166059","article-title":"Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development","volume":"14","author":"Paramithiotis","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb1415","article-title":"Optimizing humoral immunity for durable and broad protection in Flavivirus vaccines","volume":"13","author":"Park","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb1420","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.7150\/thno.16135","article-title":"RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated Salmonella-mediated cancer therapy","volume":"6","author":"Park","year":"2016","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1425","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2217\/fmb-2017-0128","article-title":"Causes of impaired oral vaccine efficacy in developing countries","volume":"13","author":"Parker","year":"2018","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1430","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/mp0600889","article-title":"Engineering bacterial vectors for delivery of genes and proteins to antigen-presenting cells","volume":"4","author":"Parsa","year":"2007","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1435","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.smim.2010.02.002","article-title":"Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy","volume":"22","author":"Paterson","year":"2010","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1440","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.2147\/IDR.S544665","article-title":"Vaccines as potential frontliners against antimicrobial resistance (AMR): a focused review","volume":"18","author":"Patil","year":"2025","journal-title":"Infect. Drug Resist."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129276","article-title":"Oral delivery of a novel attenuated Salmonella vaccine expressing influenza A virus proteins protects mice against H5N1 and H1N1 viral infection","volume":"10","author":"Pei","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1450","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/IAI.00130-11","article-title":"Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B","volume":"79","author":"Permpoonpattana","year":"2011","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1455","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17651-0","article-title":"Site-specific chromosomal gene insertion: Flp recombinase versus Cas9 nuclease","volume":"7","author":"Phan","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1460","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0013-2018","article-title":"Listeria monocytogenes: cell biology of invasion and intracellular growth","volume":"6","author":"Pizarro-Cerda","year":"2018","journal-title":"Microbiol. Spectrum"},{"issue":"17","key":"10.1016\/j.biotechadv.2026.109078_bb1465","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1128\/AEM.01103-10","article-title":"Display of recombinant proteins on Bacillus subtilis spores, using a coat-associated enzyme as the carrier","volume":"76","author":"Potot","year":"2010","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1470","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.675219","article-title":"Safety of a novel Listeria monocytogenes-based vaccine vector expressing NcSAG1 (Neospora caninum surface antigen 1)","volume":"11","author":"Pownall","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1480","article-title":"Engineering smart bacteria for the next generation","volume":"7","author":"Qiao","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1475","article-title":"Recombinant lactic acid bacteria as promising vectors for mucosal vaccination, exploration","volume":"1","author":"Qiao","year":"2021","journal-title":"Wiley Online Library"},{"issue":"35","key":"10.1016\/j.biotechadv.2026.109078_bb1485","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2008.06.030","article-title":"Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against toxoplasma gondii infection in mice","volume":"26","author":"Qu","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1490","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1038\/s41467-025-60461-6","article-title":"Identifying T cell antigen at the atomic level with graph convolutional network","volume":"16","author":"Que","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1495","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1500","article-title":"Plasmid costs explain plasmid maintenance, irrespective of the nature of compensatory mutations","volume":"12","author":"Rebelo","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"13\u201314","key":"10.1016\/j.biotechadv.2026.109078_bb1505","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0264-410X(02)00027-0","article-title":"Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations","volume":"20","author":"Reveneau","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1510","doi-asserted-by":"crossref","DOI":"10.1186\/1477-3155-1-6","article-title":"Emerging applications of bacterial spores in nanobiotechnology","volume":"1","author":"Ricca","year":"2003","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1515","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrmicro.2017.172","article-title":"Engineering bacteria for diagnostic and therapeutic applications","volume":"16","author":"Riglar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1520","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128431","article-title":"Evaluating Lactococcus lactis as a novel antiparasitic vaccine delivery platform: A scoping review of immunization routes and immunological outcomes","volume":"79","author":"Rihs","year":"2026","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1525","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/IAI.01972-06","article-title":"Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice","volume":"75","author":"Roche","year":"2007","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb1530","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/j.xphs.2021.04.018","article-title":"Current approaches of preservation of cells during (freeze-) drying","volume":"110","author":"Rockinger","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1535","first-page":"62","article-title":"Recent advances in the development of live, attenuated bacterial vectors","volume":"7","author":"Roland","year":"2005","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1540","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1641997","article-title":"Humoral response induced after intranasal vaccination with heat inactivated Acinetobacter baumannii protects immunodeficient mice against hypervirulent LAC-4 strain","volume":"16","author":"Rouma","year":"2025","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.biotechadv.2026.109078_bb1545","doi-asserted-by":"crossref","first-page":"10880","DOI":"10.3390\/ijms241310880","article-title":"The bacterial spore as a mucosal vaccine delivery system","volume":"24","author":"Saggese","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2026.109078_bb1550","article-title":"M cell-derived vesicles suggest a unique pathway for trans-epithelial antigen delivery","volume":"3","author":"Sakhon","year":"2015","journal-title":"Tissue Barriers"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1555","article-title":"Next-generation vaccines leveraging T cell-centric design, mucosal immunity, and trained innate immunity for respiratory and enteric pathogens","volume":"14","author":"Salam","year":"2026","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1560","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00134","article-title":"Live vaccination tactics: possible approaches for controlling visceral leishmaniasis","volume":"5","author":"Saljoughian","year":"2014","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1565","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/2230-973X.82384","article-title":"Recent trends in vaccine delivery systems: a review","volume":"1","author":"Saroja","year":"2011","journal-title":"Int. J. Pharm. Investig."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1570","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-micro-052821-031444","article-title":"Bacterial outer membrane vesicles: from discovery to applications","volume":"75","author":"Sartorio","year":"2021","journal-title":"Ann. Rev. Microbiol."},{"issue":"35","key":"10.1016\/j.biotechadv.2026.109078_bb1575","doi-asserted-by":"crossref","first-page":"12548","DOI":"10.1073\/pnas.0503407102","article-title":"Real-time imaging of type III secretion: Salmonella SipA injection into host cells","volume":"102","author":"Schlumberger","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb1580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001406","article-title":"Single dose novel Salmonella vaccine enhances resistance against Visceralizing L. major and L. donovani infection in susceptible BALB\/c mice","volume":"5","author":"Schroeder","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb1585","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109078_bb1590","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.0803742","article-title":"An anti-vascular endothelial growth factor receptor 2\/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2\/neu+ breast tumors in a mouse model","volume":"182","author":"Seavey","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1595","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/1078-0432.CCR-08-2283","article-title":"A novel human Her-2\/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2\/neu-positive breast tumors","volume":"15","author":"Seavey","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1600","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1419527","article-title":"Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake","volume":"15","author":"Seefeld","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb1605","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0167-7799(02)02075-9","article-title":"Lactobacilli as live vaccine delivery vectors: progress and prospects","volume":"20","author":"Seegers","year":"2002","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1610","article-title":"Editorial: data-driven vaccine design for microbial-associated diseases","volume":"16","author":"Selvaraj","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1615","doi-asserted-by":"crossref","DOI":"10.1007\/s12026-026-09763-5","article-title":"An integrated AI-driven vaccine design process: a systematic review of workflows from generative design to translational prediction","volume":"74","author":"Shafaati","year":"2026","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1620","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/cgt.2010.48","article-title":"Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2\/neu-overexpressing cancers in human","volume":"18","author":"Shahabi","year":"2011","journal-title":"Cancer Gene Ther."},{"issue":"Supplement_1","key":"10.1016\/j.biotechadv.2026.109078_bb1625","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/jpids\/piz083","article-title":"Understanding immunity in children vaccinated with live attenuated influenza vaccine","volume":"9","author":"Shannon","year":"2020","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1630","article-title":"TLR agonists as adjuvants for viral vaccines: mechanisms, applications, and future directions","volume":"16","author":"Shao","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1635","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01485","article-title":"B-vitamin sharing promotes stability of gut microbial communities","volume":"10","author":"Sharma","year":"2019","journal-title":"Front. Microbiol."},{"issue":"20","key":"10.1016\/j.biotechadv.2026.109078_bb1640","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1128\/JVI.75.20.9665-9670.2001","article-title":"Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8+ T cells and antiviral protective immunity","volume":"75","author":"Shata","year":"2001","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1645","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00003-13","article-title":"Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice","volume":"20","author":"Shi","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1650","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biotechadv.2011.12.005","article-title":"Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli","volume":"30","author":"Silva","year":"2012","journal-title":"Biotechnol. Adv."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1655","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1080\/87559129.2021.1950176","article-title":"Chitosan, chitooligosaccharides and their polyphenol conjugates: preparation, bioactivities, functionalities and applications in food systems","volume":"39","author":"Singh","year":"2023","journal-title":"Food Rev. Int."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1660","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/JVI.79.3.1452-1462.2005","article-title":"Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif","volume":"79","author":"Someya","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1665","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2022.111651","article-title":"Microencapsulating role of whey protein isolate and sucrose in protecting the cell membrane and enhancing survival of probiotic lactobacilli strains during spray drying, storage, and simulated gastrointestinal passage","volume":"159","author":"Sompach","year":"2022","journal-title":"Food Res. Int."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1675","article-title":"Vaccine strategies to elicit mucosal immunity","volume":"12","author":"Song","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1670","first-page":"209","article-title":"Recombinant Salmonella vaccination technology and its application to human bacterial pathogens","volume":"14","author":"Song","year":"2013","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"17\u201318","key":"10.1016\/j.biotechadv.2026.109078_bb1680","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.vaccine.2005.01.009","article-title":"Plasmid maintenance systems suitable for GMO-based bacterial vaccines","volume":"23","author":"Spreng","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1685","first-page":"249","article-title":"The stability of bacterial vaccines at elevated temperatures","volume":"41","author":"Stainer","year":"1978","journal-title":"Dev. Biol. Stand."},{"issue":"5483","key":"10.1016\/j.biotechadv.2026.109078_bb1690","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"Steidler","year":"2000","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biotechadv.2026.109078_bb1695","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1128\/IAI.72.10.5622-5629.2004","article-title":"Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants","volume":"72","author":"Stritzker","year":"2004","journal-title":"Infect. Immun."},{"issue":"40","key":"10.1016\/j.biotechadv.2026.109078_bb1700","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2016.08.002","article-title":"Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators","volume":"34","author":"Sumner","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1705","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-94-024-0890-4_12","article-title":"Plague vaccines: status and future","volume":"918","author":"Sun","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109078_bb1715","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3855\/jidc.2030","article-title":"Developing live vaccines against plague","volume":"5","author":"Sun","year":"2011","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1710","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-019-0105-9","article-title":"Plague vaccine: recent progress and prospects","volume":"4","author":"Sun","year":"2019","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1720","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jam.13446","article-title":"Lactic acid bacteria\u2014promising vaccine vectors: possibilities, limitations, doubts","volume":"123","author":"Szatraj","year":"2017","journal-title":"J. Appl. Microbiol."},{"issue":"7\u20138","key":"10.1016\/j.biotechadv.2026.109078_bb1725","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0923-2508(90)90141-C","article-title":"Recombinant bacterial ghosts as vaccines","volume":"141","author":"Szostak","year":"1990","journal-title":"Res. Microbiol."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1730","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.copbio.2004.10.004","article-title":"Bacterial ghosts\u2013biological particles as delivery systems for antigens, nucleic acids and drugs","volume":"15","author":"Tabrizi","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1735","series-title":"Chitosan Based Biomaterials Volume 2","first-page":"245","article-title":"9 - antimicrobial applications of chitosan","author":"Tachaboonyakiat","year":"2017"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1740","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0264-410X(92)90392-W","article-title":"Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain","volume":"10","author":"Tacket","year":"1992","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1745","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/iai.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans","volume":"65","author":"Tacket","year":"1997","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1750","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1755","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.omtm.2022.05.012","article-title":"Impact of genetically modified organism requirements on gene therapy development in the EU, Japan, and the US","volume":"26","author":"Tajima","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1760","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00783","article-title":"Outer membrane vesicles: current status and future direction of these novel vaccine adjuvants","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1765","article-title":"Past, present, and future of viral vector vaccine platforms: a comprehensive review","volume":"13","author":"Tang","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1770","doi-asserted-by":"crossref","DOI":"10.3390\/cells14070494","article-title":"Therapeutic targets in glioblastoma: molecular pathways, emerging strategies, and future directions","volume":"14","author":"Tang","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1775","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13036-023-00379-z","article-title":"Engineered live bacteria as disease detection and diagnosis tools","volume":"17","author":"Tanniche","year":"2023","journal-title":"J. Biol. Eng."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb1780","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309088","article-title":"Synthetic gene circuits for regulation of next-generation cell-based therapeutics","volume":"11","author":"Teixeira","year":"2024","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1785","article-title":"Genetic rearrangement during site specific integration event facilitates cell line development of a bispecific molecule","volume":"37","author":"Tevelev","year":"2021","journal-title":"Biotechnol. Prog."},{"issue":"6","key":"10.1016\/j.biotechadv.2026.109078_bb1790","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101104","article-title":"Comparing mucosal immunity induced by type 2 oral poliovirus vaccines","volume":"6","author":"Thompson","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.biotechadv.2026.109078_bb1795","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2025.106971","article-title":"The benefits of Lactiplantibacillus plantarum: from immunomodulator to vaccine vector","volume":"272","author":"Tobias","year":"2025","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1800","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/EBC20160013","article-title":"Synthetic biology approaches to biological containment: pre-emptively tackling potential risks","volume":"60","author":"Torres","year":"2016","journal-title":"Essays Biochem."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1805","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1810","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119299","article-title":"Aptamers in cancer therapy: why has clinical translation lagged behind preclinical promise?","volume":"198","author":"Tran","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1815","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2026.103884","article-title":"Lipid\/copolymer hybrid drug delivery systems: from design to performance","volume":"353","author":"Triantafyllopoulou","year":"2026","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"1_Supplement","key":"10.1016\/j.biotechadv.2026.109078_bb1820","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.4049\/jimmunol.178.Supp.41.14","article-title":"Co-expression of Yersinia pestis F1- and V-Ags by the same Salmonella vaccine protects against Nasal Y. pestis challenge (41.14)","volume":"178","author":"Trunkle","year":"2007","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.biotechadv.2026.109078_bb1825","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1016\/j.vaccine.2007.01.028","article-title":"Receptor mediated targeting of M-cells","volume":"25","author":"Tyrer","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109078_bb1830","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"Van Der Pol","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1835","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.csbj.2023.02.007","article-title":"Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein","volume":"21","author":"Vetr\u00e1kov\u00e1","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1840","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41541-025-01258-y","article-title":"AI-driven epitope prediction: a system review, comparative analysis, and practical guide for vaccine development","volume":"10","author":"Villanueva-Flores","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1845","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/IAI.67.7.3680-3685.1999","article-title":"Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria","volume":"67","author":"Viret","year":"1999","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1855","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ncomms1516","article-title":"Engineering modular and orthogonal genetic logic gates for robust digital-like synthetic biology","volume":"2","author":"Wang","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1865","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/563838","article-title":"Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B","volume":"2012","author":"Wang","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1885","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13578-024-01207-7","article-title":"Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions","volume":"14","author":"Wang","year":"2024","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1890","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41541-024-01004-w","article-title":"Immune correlates of protection as a game changer in tuberculosis vaccine development","volume":"9","author":"Wang","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb1850","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1128\/IAI.69.8.4734-4741.2001","article-title":"Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915","volume":"69","author":"Wang","year":"2001","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb1875","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.4161\/hv.36174","article-title":"Roles of M cells in infection and mucosal vaccines","volume":"10","author":"Wang","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1880","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1523","article-title":"Outer membrane vesicles for vaccination and targeted drug delivery","volume":"11","author":"Wang","year":"2019","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1870","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.micpath.2012.10.006","article-title":"New technologies in developing recombinant attenuated Salmonella vaccine vectors","volume":"58","author":"Wang","year":"2013","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1895","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41392-024-01917-x","article-title":"Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1860","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/IAI.00445-10","article-title":"Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines","volume":"79","author":"Wang","year":"2011","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1905","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf1472","article-title":"A unified computational framework for quantitative design and optimization of transcriptional regulation across bacterial species","volume":"54","author":"Wang","year":"2026","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1910","article-title":"Advanced strategies for the diagnosis, treatment, and vaccination of monkeypox","volume":"24","author":"Wang","year":"2026","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1900","first-page":"69","article-title":"Emerging strategies for monkeypox: antigen and antibody applications in diagnostics, vaccines, and treatments","volume":"12","author":"Wang","year":"2025","journal-title":"Mil. Med. Res."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1915","doi-asserted-by":"crossref","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1920","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrmicro1840","article-title":"Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria","volume":"6","author":"Wells","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1925","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13036-018-0105-8","article-title":"Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications","volume":"12","author":"Whitford","year":"2018","journal-title":"J. Biol. Eng."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb1930","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/acs.molpharmaceut.3c00844","article-title":"Clinical and preclinical methods of heat-stabilization of human vaccines","volume":"21","author":"Williamson","year":"2024","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1940","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00262-011-1129-9","article-title":"The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy","volume":"61","author":"Wood","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1935","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2014.00051","article-title":"Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy","volume":"4","author":"Wood","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.biotechadv.2026.109078_bb1945","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1111\/jam.15720","article-title":"A SARS-CoV-2 oral vaccine development strategy based on the attenuated Salmonella type III secretion system","volume":"133","author":"Wu","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1950","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139302","article-title":"Interaction between interleukin-12 (IL-12) and its receptor (IL-12Rbeta2) mediates CD4(+) T cell subsets activation in flounder (Paralichthys olivaceus)","volume":"293","author":"Wu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1955","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s00253-015-6498-0","article-title":"Lactic acid bacteria\u201420 years exploring their potential as live vectors for mucosal vaccination","volume":"99","author":"Wyszy\u0144ska","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1960","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/IAI.01623-07","article-title":"Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar typhimurium vaccine with regulated delayed antigen synthesis","volume":"76","author":"Xin","year":"2008","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb1970","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12879-018-3104-y","article-title":"Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection","volume":"18","author":"Xu","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.biotechadv.2026.109078_bb1965","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/IAI.00298-10","article-title":"Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines","volume":"78","author":"Xu","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2026.109078_bb1975","first-page":"39","article-title":"M cell-targeted mucosal vaccine strategies","volume":"354","author":"Yamamoto","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb1980","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160882","article-title":"Efficacy of tumor-targeting Salmonella A1-R on a melanoma patient-derived Orthotopic xenograft (PDOX) nude-mouse model","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.biotechadv.2026.109078_bb1985","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.fsi.2013.01.027","article-title":"Asd-based balanced-lethal system in attenuated Edwardsiella tarda to express a heterologous antigen for a multivalent bacterial vaccine","volume":"34","author":"Yan","year":"2013","journal-title":"Fish Shellfish Immunol."},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb1990","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.145.7.2281","article-title":"Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis","volume":"145","author":"Yang","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb2000","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.micpath.2014.03.011","article-title":"Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL\/6 mice","volume":"69-70","author":"Yang","year":"2014","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb1995","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4049\/jimmunol.178.2.1059","article-title":"Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague","volume":"178","author":"Yang","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.biotechadv.2026.109078_bb2005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.vaccine.2015.01.031","article-title":"Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens","volume":"33","author":"Yang","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biotechadv.2026.109078_bb2010","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s10068-024-01802-x","article-title":"Enhanced preservation of viability and species stratification in Lacticaseibacillus group using Levan-fortified skim milk as a cryoprotectant during freeze-drying","volume":"34","author":"Yavuz","year":"2025","journal-title":"Food Sci. Biotechnol."},{"key":"10.1016\/j.biotechadv.2026.109078_bb2015","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2026.07.005","article-title":"Plasmid copy number control offers a versatile tool in synthetic biology applications","author":"Yong","year":"2026","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb2020","article-title":"Development of an oral salmonella-based vaccine platform against SARS-CoV-2","volume":"10","author":"Yoon","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.biotechadv.2026.109078_bb2025","doi-asserted-by":"crossref","DOI":"10.3390\/medsci6020027","article-title":"Live bacterial vectors-A promising DNA vaccine delivery system","volume":"6","author":"Yurina","year":"2018","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb2035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41541-025-01255-1","article-title":"Synthetic biology-inspired development of live attenuated influenza vaccines","volume":"10","author":"Zhang","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"17","key":"10.1016\/j.biotechadv.2026.109078_bb2030","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.01096-20","article-title":"Applications of Bacillus subtilis spores in biotechnology and advanced materials","volume":"86","author":"Zhang","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb2040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s43556-025-00301-7","article-title":"Mucosal immunity and vaccination strategies: current insights and future perspectives","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.biotechadv.2026.109078_bb2055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jare.2025.10.028","article-title":"Programmable microbial therapeutics: advances in engineered bacteria for targeted in vivo delivery and precision medicine","volume":"85","author":"Zhao","year":"2025","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.biotechadv.2026.109078_bb2045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.0408422102","article-title":"Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb2050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.biotechadv.2026.109078_bb2060","doi-asserted-by":"crossref","DOI":"10.3390\/vetsci11080353","article-title":"Recent advances in oral vaccines for animals","volume":"11","author":"Zhong","year":"2024","journal-title":"Vet. Sci."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb2070","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb2080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-024-02043-4","article-title":"Mucosal immune response in biology, disease prevention and treatment","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biotechadv.2026.109078_bb2075","article-title":"Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2026.109078_bb2065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1099\/jmm.0.076430-0","article-title":"Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores","volume":"64","author":"Zhou","year":"2015","journal-title":"J. Med. Microbiol."},{"issue":"12","key":"10.1016\/j.biotechadv.2026.109078_bb2085","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00335-25","article-title":"Klebsiella pneumoniae ghosts as a novel adjuvant drive dendritic cell maturation and antigen-specific TCM expansion for IFN-\u03b3-mediated immune protection","volume":"93","author":"Zhu","year":"2025","journal-title":"Infect. Immun."}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975026002843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975026002843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:26:04Z","timestamp":1792524364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975026002843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":417,"alternative-id":["S0734975026002843"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2026.109078","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programmable bacterial vaccine vectors: A Design\u2013Build\u2013Control framework for precision immune engineering","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2026.109078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109078"}}